Prevention of cardiovascular disease in type 2 diabetic patients
Yokota, C.
Nihon Rinsho. Japanese Journal of Clinical Medicine 61(7): 1161-1166
2003
ISSN/ISBN: 0047-1852 PMID: 12877078 Document Number: 555785
Cardiovascular morbidity is a major burden in patients with type 2 diabetes. Many national guidelines for the treatment of type 2 diabetes recommend reducing the risk of multiple factors through the use of protocols and therapeutic targets. The current several important studies suggests that a long-term, targeted, intensive intervention involving multiple risk factors reduces the risk of both cardio-cerebro-vascular and microvascular events among patients with type 2 diabetes.
Document emailed within 1 workday
Related Documents
Chen, Y.; Wang, J.; An, Y.; Gong, Q.; He, Y.; Zhang, B.; Li, H.; Shuai, Y.; Tang, X.; Jiang, Y.; Hong, J.; Yang, W.; Hu, Y.; Li, G. 2015: Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study Zhonghua Nei Ke Za Zhi 54(1): 13-172005: To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too MMWFortschrittederMedizin 147(33-34): 51
Birkeland, K.I.; Claudi, T.; Hansteen, V.; Hanssen, K.F.; Hjermann, I.; Jenssen, T.; Jervell, J.; Os, I. 2000: Prevention of cardiovascular disease in type 2 diabetes Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(21): 2554-2559
Huszno, B.; Trofimiuk, M.; Płaczkiewicz, E.; Pach, D.; Szurkowska, M.; Szybiński, Z.; Gołkowski, F. 2001: Co-occurrence of diabetic gastropathy and cardiovascular vegetative neuropathy in patients with diabetes type 1 Folia Medica Cracoviensia 42(3): 105-111
Onuchin, S.G.; Elsukova, O.S.; Solov'ev, O.V.; Onuchina, E.L. 2010: Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy Klinicheskaia Meditsina 88(1): 32-37
Maciá Bobes, C.; Ronzón Fernández, Aánzazu.; Fernández García, E. 2007: Primary prevention with aspirin for cardiovascular diseases in diabetic patients. What evidence supports the criteria of the ADA? Atencion Primaria 39(3): 163-164
Knight, K.M.; Thornburg, L.L.; Pressman, E.K. 2012: Pregnancy outcomes in type 2 diabetic patients as compared with type 1 diabetic patients and nondiabetic controls Journal of Reproductive Medicine 57(9-10): 397-404
Chmielecki, K.; Mroszczyk, M.; Loba, J.; Torzecka, W.; Chromińska, D.; Szosland, K. 1982: Cardiovascular disease mortality among diabetic patients in the city of Lodz Wiadomosci Lekarskie 35(18): 1113-1117
Eckert, S.; Tschöpe, D. 2005: Cardiovascular protection in diabetic patients with heart disease in the doctor's office MMW Fortschritte der Medizin 147(43): 43-46
Joshi, M.D.; Amayo, E.O. 2006: Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi East African Medical Journal 83(7): 405-6; author reply 406-7
Joshi, M.D.; Amayo, E.O. 2006: Cardiovascular risk factors in patients with type 2 diabetes mellitus in Kenya: levels of control attained at the Outpatient Diabetic Clinic of Kenyatta National Hospital, Nairobi East African Medical Journal 83(7): 405-6; author reply 406-7
Migdalis, I.N.; Dimakopoulos, N.; Kourti, A.; Tolis, A.; Koutoulidis, K.; Samartzis, M. 1994: The prevalence of peripheral vascular disease in type 2 diabetic patients with and without proteinuria International Angiology: a Journal of the International Union of Angiology 13(3): 229-232
Kogan, B.M.; Kuz'mishin, L.E.; Lavrova, D.I.; Sokolova, D.A.; Andreeva, O.S. 1981: Cardiovascular function in coronary disease depending on the type of patients' occupations Sovetskaia Meditsina 8: 9-13
Dumitrescu, C.; Cheţa, D.; Lichiardopol, R.; Străchinariu, N.; Sântu, E.; Georgescu, M.; Cocioabă, G.; Mincu, I. 1987: The frequency of diabetes mellitus in parents of diabetic patients relative to disease type Medecine Interne 25(4): 289-295
Spiess, K.; Sachs, G.; Frischenschlager, O.; Moser, G.; Prager, R. 1994: Phase-specific function of denial in type 1 diabetic patients after disease onset Zeitschrift für Psychosomatische Medizin und Psychoanalyse 40(1): 52-67
Casoinic, F.; Sâmpelean, D.; Bădău, C.ăt.ăl.; Prună, L. 2009: Nonalcoholic fatty liver disease--a risk factor for microalbuminuria in type 2 diabetic patients Romanian Journal of Internal Medicine 47(1): 55-59
Hovens, M.M.C.; Cannegieter, S.C. 2004: Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease Nederlands Tijdschrift Voor Geneeskunde 148(42): 2097; Author Reply 2097-8
Kopeć, G.; Podolec, P. 2009: Target patients for polyunsaturated omega-3 fatty acids in cardiovascular disease prevention Kardiologia Polska 67(11): 1299-1303
Halim, E.F.A.E.; Reda, A.A.; Hendi, A.A.K.; Zaki, S.A.; Essa, E.S.; Khalifa, A.S. 2012: Apolipoprotein e gene variants as a risk factor for coronary artery disease in type 2 diabetic Egyptian patients Egyptian Journal of Immunology 19(1): 1-10
Lowe, G.; Rumley, A.; Norrie, J.; Ford, I.; Shepherd, J.; Cobbe, S.; Macfarlane, P.; Packard, C. 2000: Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study Thrombosis and Haemostasis 84(4): 553-558